Home » EMA: Use of Off-Label, Unauthorized Medicines for Children Needs Attention
EMA: Use of Off-Label, Unauthorized Medicines for Children Needs Attention
February 16, 2011
The widespread use of off-label and unauthorized medicines to treat children in Europe requires regulatory review, according to a report published by the European Medicines Agency (EMA). Includes the full text of the EMA Report on All Pediatric Uses Of Medicinal Products in Europe.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor